CURRICULUM VITAE. Edward I. Cho, M.D. House Clinic 2100 West 3 rd Street Suite 111 Los Angeles, CA (213)

Transcription

1 CURRICULUM VITAE Edward I. Cho, M.D. House Clinic 2100 West 3 rd Street Suite 111 Los Angeles, CA (213) EDUCATION B.A., Cornell University, Ithaca, NY, M.D., Yale University School of Medicine, New Haven, CT, RESIDENCY Intern, Department of Surgery, Cleveland Clinic, Cleveland, OH, Resident in Otolaryngology, Cleveland Clinic, Cleveland, OH, Chief Resident in Otolaryngology, Cleveland Clinic, Cleveland, OH, Postdoctoral Fellow in Vestibular and Balance Disorders, Cleveland Clinic, Cleveland, OH, CLINICAL APPOINTMENTS BOARD CERTIFICATION Clinical Associate Staff in Otolaryngology, Cleveland Clinic, Cleveland, OH Clinical Faculty in Otolaryngology, MetroHealth Medical Center, Cleveland, OH 2011-Present. Assistant Professor in Otolaryngology, Case Western Reserve University School of Medicine, Cleveland, OH State of Ohio, Medical Board, 2010-Present. State of California, Medical Board, 2013-Present. Board Certified, American Board of Otolaryngology, 6/1/2011-Present, #20296.

2 SOCIETY MEMBERSHIPS HONORS & AWARDS RESEARCH EXPERIENCE American Academy of Otolaryngology Head and Neck Surgery Los Angeles Society of Otolaryngology American Neurotology Society Jackson Laboratory Summer Student Program, Bar Harbor, ME, Baylor College of Medicine Summer Medical and Research Training Program (SMART), Houston, TX, Michael DeBakey Summer Surgery Program, Methodist Hospital, Houston, TX, NIH-NHLBI Summer Research Fellowship, Yale University School of Medicine, New Haven, CT, Doris Duke Clinical Research Fellowship, Yale University School of Medicine, New Haven, CT, Farr Scholar for Research Excellence, Yale University School of Medicine, New Haven, CT, Research Program Council Grant ($25,000), Cleveland Clinic, Cleveland, OH, Head and Neck Institute 6 th Annual Lazar Family Lecture, First Place Research Presentation, Cleveland Clinic, Cleveland, OH, NE OH Otolaryngology Head and Neck Society, First Place Research Presentation, Cleveland, OH, Research Assistant: Creation of a targeting vector for the functional mapping of mouse chromosome 17. Jackson Laboratory, Bar Harbor, ME. Summer Research Assistant: Adenovirus-mediated regulable target gene expression in vivo. Baylor College of Medicine, Houston, TX. Summer 1997.

3 Research Fellow: Calcium-pump inhibitors induce functional surface expression of F508-CFTR protein in cystic fibrosis epithelial cells. Yale University School of Medicine, New Haven, CT. Summer Doris Duke Research Fellow: Molecular tumor markers as prognostic indicators in early stage larynx cancer. Yale University School of Medicine, New Haven, CT Research Fellow: Toll-like receptor agonists as third signals for dendritic celltumor fusion vaccines. Cleveland Clinic, Cleveland, OH SCIENTIFIC PRESENTATIONS 1. Cho E, Schimenti, J. Creation of a targeting vector for the functional mapping of mouse chromosome 17. Oral Presention at the Jackson Laboratory Summer Student Symposium, Bar Harbor, ME. August 12, Cho EI, Kowalski DP, Sasaki CT, Haffty BG. Molecular tumor markers as prognostic indicators in early stage larynx cancer. Poster Presentation at the 2003 Annual National Meeting, Doris Duke Clinical Research Fellowship, Cold Spring Harbor, NY. June 24-26, Cho EI, Sasaki CT, Haffty BG. Prognostic value of pretreatment hemoglobin for local control and overall survival in T1-2N0 larynx cancer treated with external beam radiation therapy. Oral Presentation at 89 th Scientific Assembly and Annual Meeting of the Radiological Society of North America, Chicago, IL. November 30-December 5th, Cho EI, Kowalski DP, Sasaki CT, Haffty BG. Tissue microarray analysis reveals prognostic significance of COX-2 expression for local relapse in T1-2N0 larynx cancer treated with primary radiation therapy. Oral Presentation at the Triological Society, Eastern Section Meeting, New York, NY. January 23-25, Cho EI, Kowalski DP, Sasaki CT, Haffty BG. Prognostic significance of COX-2 in early stage larynx cancer treated with radiation therapy. Poster Presentation at Student Research Day, Yale University School of Medicine, New Haven, CT. May 11, Cho EI, Tan C, Koski G, Cohen P, Shu S, Lee, W. Toll-like receptor agonists as adjuvants for dendritic cell-tumor fusion vaccines. Oral Presentation at the Cleveland Clinic Head and Neck Institute, 6 th Annual Lazar Family Resident Research Day, Cleveland Clinic, Cleveland, OH. June 21, Cho EI, Tan C, Koski G, Cohen P, Shu S, Lee, W. Toll-like receptor agonists as 3 rd signals for dendritic cell-tumor fusion vaccines. Oral Presentation at the Triological Society, Combined Southern and Middle Section Meetings, Bonita Springs, FL. January 11, 2009.

4 8. Cho EI, White JA. Intratympanic steroids in the treatment of Meniere s disease. Poster Presentation at the Association for Research in Otolaryngology, 34 th Midwinter Meeting, Baltimore, MD. February 20, SCIENTIFIC PUBLICATIONS AND ABSTRACTS 1. Egan ME, Glockner-Pagel J, Ambrose, CA, Cahill PA, Pappoe L, Balamuth N, Cho E, Canny S, Wagner CA, Geibel J, Caplan MJ. Calcium-pump inhibitors induce functional surface expression of F508-CFTR protein in cystic fibrosis epithelial cells. Nature Medicine. 8(5): , Cho EI, Sasaki CT, Haffty BG. Prognostic value of pretreatment hemoglobin for local control and overall survival in T1-2N0 larynx cancer treated with external beam radiation therapy. International Journal of Radiation Oncology, Biology, Physics. 58(4): , Cho EI, Kowalski DP, Sasaki CT, Haffty BG. Tissue microarray analysis reveals prognostic significance of COX-2 expression for local relapse in T1-2N0 larynx cancer treated with primary radiation therapy. Laryngoscope. 114(11):2001-8, Haffty BG, Son YH, Wilson LD, Cho EI, Papac RJ, Fischer DB, Rockwell S, Sartorelli AC, Sasaki CT, Fischer JJ. Concurrent chemo-radiotherapy with mitomycin-c (MC) compared to porfiromycin (PO) in squamous cell carcinoma of the head and neck (SCCHN): final results of a randomized clinical trial. International Journal of Radiation Oncology, Biology, Physics. 61(1):119-28, Cho EI, Tan C, Koski GK, Cohen PA, Shu S, Lee WT. Toll-like receptor agonists as third signals for dendritic cell-tumor fusion vaccines. Head and Neck. 32(6):700-7, Cho EI, White JA. Positional vertigo: As occurs across all age groups. Otolaryngologic Clinics of North America. 44(2):347-60, ACADEMIC PRESENTATIONS 1. Diagnosis and management of superior semicircular canal dehiscence. Cleveland Clinic Head and Neck Institute Grand Rounds, Cleveland Clinic, Cleveland, OH. January 4, Cochlear implants. Cleveland Clinic Head and Neck Institute Grand Rounds, Cleveland Clinic, Cleveland, OH. March 21, Diagnosis and management of bilateral vestibular hypofunction. Cleveland Clinic Head and Neck Institute Grand Rounds, Cleveland Clinic, Cleveland, OH. September 5, 2007.

5 4. Diagnosis and management of hereditary medullary thyroid cancer. Cleveland Clinic Head and Neck Institute Grand Rounds, Cleveland Clinic, Cleveland, OH. May 6, Medical Management of Vertigo. Los Angeles Society of Otolaryngology Head and Neck Surgery, House Ear Institute, Los Angeles, CA. October 21, Vestibular Testing and Interpretation. St. Vincent Hospital Grand Rounds, St. Vincent Hospital, Los Angeles, CA. January 31, 2014